Related Experiment Videos
Penetration of spectinomycin into cerebrospinal fluid duirng experimental meningitis
Abstract:
The concentration of spectinomycin in serum and cerebrospinal fluid was compared in rabbits with and without experimental pneumococcal meningitis. When injected intravenously, spectinomycin could not be detected in the cerebrospinal fluid of normal rabbits. In rabbits with meningeal inflammation, however, spectinomycin penetrated the blood-brain barrier and produced significant cerebrospinal fluid concentrations, equal to or well above spectinomycin minimal inhibitory concentrations for many bacterial species.
Insights
Spectinomycin did not enter cerebrospinal fluid in healthy rabbits. However, in rabbits with pneumococcal meningitis, spectinomycin effectively crossed the blood-brain barrier, reaching therapeutic concentrations in cerebrospinal fluid.
Area of Science:
- Pharmacology
- Infectious Diseases
- Neurology
Background:
- The blood-brain barrier (BBB) restricts drug entry into the central nervous system.
- Effective antibiotic penetration is crucial for treating bacterial meningitis.
Purpose of the Study:
- To evaluate spectinomycin's penetration into cerebrospinal fluid (CSF) in a rabbit model of pneumococcal meningitis.
- To determine if inflammation enhances spectinomycin's BBB permeability.
Main Methods:
- Intravenous spectinomycin administration in rabbits with and without experimentally induced pneumococcal meningitis.
- Quantification of spectinomycin concentrations in serum and CSF via validated analytical methods.
Main Results:
- Spectinomycin was undetectable in the CSF of normal rabbits.
- In rabbits with meningitis, significant CSF spectinomycin concentrations were achieved.
- CSF levels were comparable to or exceeded minimal inhibitory concentrations (MICs) for various bacterial pathogens.
Conclusions:
- Experimental pneumococcal meningitis significantly enhances spectinomycin's penetration across the blood-brain barrier.
- Spectinomycin demonstrates potential therapeutic utility for CNS infections when BBB is compromised by inflammation.